Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Perinatal Medicine

Official Journal of the World Association of Perinatal Medicine

Editor-in-Chief: Dudenhausen, MD, FRCOG, Joachim W.

Editorial Board Member: / Bancalari, Eduardo / Greenough, Anne / Genc, Mehmet R. / Chervenak, Frank A. / Chappelle, Joseph / Bergmann, Renate L. / Bernardes, J.F. / Bevilacqua, G. / Blickstein, Isaac / Cabero Roura, Luis / Carbonell-Estrany, Xavier / Carrera, Jose M. / D`Addario, Vincenzo / D'Alton, MD, Mary E. / Dimitrou, G. / Grunebaum, Amos / Hentschel, Roland / Köpcke, W. / Kawabata, Ichiro / Keirse, Marc J.N.C. / Kurjak M.D., Asim / Lee, Ben H. / Levene, Malcolm / Lockwood, Charles J. / Marsal, Karel / Makatsariya, Alexander / Nishida, Hiroshi / Papp, Zoltán / Pejaver, Ranjan Kumar / Pooh, Ritsuko K. / Reiss, Irwin / Romero, Roberto / Saugstad, Ola D. / Schenker, Joseph G. / Sen, Cihat / Seri, Istvan / Vetter, Klaus / Winn, Hung N. / Young, Bruce K. / Zimmermann, Roland

9 Issues per year


IMPACT FACTOR 2016: 1.577
5-year IMPACT FACTOR: 1.705

CiteScore 2016: 1.49

SCImago Journal Rank (SJR) 2016: 0.602
Source Normalized Impact per Paper (SNIP) 2016: 0.832

Online
ISSN
1619-3997
See all formats and pricing
More options …
Volume 40, Issue 1 (Jan 2012)

Issues

Combination antiretroviral therapy with protease inhibitors in HIV-infected pregnancy

Chi P. Dola
  • Department of Obstetrics and Gynecology, Tulane Health Sciences Center, Tulane University School of Medicine, New Orleans, LA, USA
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Rubina Khan
  • Department of Obstetrics and Gynecology, Ochsner Medical Center – Internal Medicine, New Orleans, LA, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Nathaniel DeNicola
  • Department of Obstetrics and Gynecology, Tulane Health Sciences Center, Tulane University School of Medicine, New Orleans, LA, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Mahin Amirgholami
  • Department of Obstetrics and Gynecology, Tulane Health Sciences Center, Tulane University School of Medicine, New Orleans, LA, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Tara Benjamin
  • Department of Obstetrics and Gynecology, Tulane Health Sciences Center, Tulane University School of Medicine, New Orleans, LA, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Azad Bhuiyan / Sherri Longo
  • Department of Obstetrics and Gynecology, Ochsner Medical Center – Internal Medicine, New Orleans, LA, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2011-11-02 | DOI: https://doi.org/10.1515/JPM.2011.111

Abstract

Objective: To evaluate the possible association between protease inhibitor (PI) and premature birth and low birth-weight in HIV-infected pregnancies.

Materials and methods: Data were collected retrospectively for maternal and pregnancy characteristics, antiretroviral medication, lowest CD4 count and highest viral load during pregnancy, and pregnancy outcomes. χ2 Analysis, Student’s t-test, and multiple logistic regression analysis were performed.

Results: Data from 161 HIV-infected women who delivered singleton gestation were analyzed. Fifty-three received an antepartum regimen with PI, 84 received a regimen without PI, and six did not receive antepartum treatment. The mean estimated gestational age (EGA)±SD at delivery was 37.7±3.2 weeks. The premature birth rate was 18.4%. No difference was detected between women receiving the antiretroviral regimen including PI and those on the regimen without PI or on no antepartum medication with regard to: EGA±SD at delivery (37.7±3.2 vs. 37.6±3.1 weeks, respectively, P=0.87), rate of premature birth (14% vs. 20.6%, respectively, P=0.32) and low birth-weight (12.5% vs. 20.2%, respectively, P=0.25). In multiple logistic regression analysis, PI was not associated with premature birth or low birth-weight.

Conclusion: Women receiving antiretroviral therapy with PI have a similar rate of premature birth and low birth-weight as women receiving antiretroviral therapy without PI or on no medication.

Keywords: Low birth-weight; preterm birth; protease inhibitors

About the article

Corresponding author: Chi P. Dola, MD, MPH Department of Obstetrics and Gynecology SL-11, Tulane School of Medicine 1430 Tulane Avenue New Orleans, LA 70112 USA Tel.: +(504) 988-5217 Fax: +(504) 988-1846


Received: 2011-04-24

Revised: 2011-08-09

Accepted: 2011-08-26

Published Online: 2011-11-02

Published in Print: 2012-01-01


Citation Information: Journal of Perinatal Medicine, ISSN (Online) 1619-3997, ISSN (Print) 0300-5577, DOI: https://doi.org/10.1515/JPM.2011.111.

Export Citation

Comments (0)

Please log in or register to comment.
Log in